Irene V Lambrinoudaki



  1. request reprint
    Lambrinoudaki I, Christodoulakos G, Panoulis C, Botsis D, Rizos D, Augoulea A, et al. Determinants of serum leptin levels in healthy postmenopausal women. J Endocrinol Invest. 2003;26:1225-30 pubmed
    ..Neither endogenous estradiol, nor endogenous testosterone are associated with leptin levels. Further studies are needed to elucidate the role of leptin in determining body weight and composition in postmenopausal women. ..
  2. Lambrinoudaki I, Christodoulakos G, Economou E, Vlachou S, Panoulis C, Alexandrou A, et al. Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene. Maturitas. 2008;59:62-71 pubmed publisher
    ..Apoptosis may be a pathway through which leptin exerts a pro-atherogenic effect. Low dose HT may act cardioprotectively by decreasing leptin levels in healthy recently menopaused women. ..
  3. request reprint
    Lambrinoudaki I, Vlachou S, Creatsas G. Genetics in gestational diabetes mellitus: association with incidence, severity, pregnancy outcome and response to treatment. Curr Diabetes Rev. 2010;6:393-9 pubmed
    ..This review focuses on possible gestational diabetes mellitus susceptibility genes and their association with the disease incidence and severity as well as the pregnancy outcome and the response to treatment. ..
  4. Artemiadis A, Lambrinoudaki I, Voskou P, Tsivgoulis G, Safouris A, Bougea A, et al. Preliminary evidence for gender effects of levetiracetam monotherapy duration on bone health of patients with epilepsy. Epilepsy Behav. 2016;55:84-6 pubmed publisher
    ..Also, LS assessments were more sensitive to these gender differences. Future larger studies should validate these results. ..
  5. Lambrinoudaki I, Kaparos G, Vlachou S, Stamatelopoulos K, Georgiopoulos G, Sergentanis T, et al. CYP A-204C polymorphism is associated with subclinical atherosclerosis in postmenopausal women. Menopause. 2008;15:1163-8 pubmed publisher
    ..It remains to be clarified whether the presence of these polymorphisms may be valuable in assessing the inherent risk among postmenopausal women. ..
  6. Lambrinoudaki I, Kaparos G, Papadimitriou D, Sergentanis T, Creatsa M, Alexandrou A, et al. Methylenetetrahydrofolate reductase C677T polymorphism is associated with central adiposity and increased androgenicity in healthy postmenopausal women. Eur J Endocrinol. 2008;159:233-41 pubmed publisher
    ..The significance of this association with respect to the CVD risk of postmenopausal women remains to be elucidated in future studies. ..